Safety of infliximab in inflammatory bowel disease needs to be debated.
until further notice
SourceClinical Gastroenterology and Hepatology, 7, 5, (2009), pp. 603-4
Article / Letter to editor
Display more detailsDisplay less details
Clinical Gastroenterology and Hepatology
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.